Belgium
Nature loving, self-directed and driven entrepreneurial CEO with comprehensive background in reorganizing, building and leading high performance organisations. Innovative thinker with strong financial performance optimization. Demonstrated success in developing and seamlessly executing strategic plans in very complex business environments. Recognized for maximizing performance by implementing strategies trough analysis of details in order to gain understanding of the competitive position, trends and relationships. Long and proven expertise in managing multi-million-dollar plants and effectively mitigating operational costs.
Takes care of you "Carey" A mobile coach app assisting your patients before and after surgery.
Small Cap Investment Company. The Essence of Red Apple is to create a future where start-ups and dead-end companies get the opportunity to pull their business to a next level. Setting up the right alignment and build deep partnerships between Red Apple investments and the business owners that will establish significant value for both parties.
Overseeing, leading,directing and representing the holding company in all of its facets with focus on operational excellence, sustainable long term profitability and strategic positioning of all business units by consolidating Nipro Medical and Nipro Pharma Packaging International. Accountability for 9 figures annual revenue and healthy EBIDTA, 35 fully structured offices across the globe and 15 fully integrated manufacturing sites in medical and pharma packaging industry, overseeing a significant number of FTE mixed between blue and white collars.
Leading the Amcor global footprint acquisition and MG Glass Germany acquisition in 2010 with successful deal closing in 2011. Additional role as CEO to oversee and implement the AMCOR Glass Acquired asset within Nipro Corporation. Accountability for 9 figure annual revenue and healthy EBITDA, 10 offices in major markets and 13 manufacturing facilities spread over USA, Europe, India and Russia.
As acting CEO, leading and growing the Renal care, Diabetes Care, Hospital Suplies and OEM Business in EMEA and Russia. Building a new high performance organisation for double digit growth, rebranding and developing a new product range for the different business units. Accountebility for 9 figure annual revenue, healthy EBITDA, 20+ fully structured offices and 2 medical manufacturing facilities.